Ngày 30/03/2020 | 08:07.

Treatment with aspirin plus rivaroxaban following lower extremity revascularisation in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with aspirin alone.

Ngày 27/03/2020 | 09:03.

A viewpoint in the Journal of the American Medical Association has offered potential solutions to modifying ongoing randomised clinical trials during the COVID-19 pandemic. It aims to “minimise disruption and preserve integrity”, while still ensuring participant health and safety.

Ngày 26/03/2020 | 09:08.

CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The company says the procedure was performed by an experienced heart team in St James’ University Hospital (Dublin, Ireland).

Ngày 25/03/2020 | 08:13.

The president of the Vascular Society of Great Britain and Ireland, Chris Imray (University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK), has issued a letter to Vascular Society members on the COVID-19 virus and vascular surgery, offering “general principles” on vascular patients and COVID-19, elective surgery and outpatients, urgent vascular surgery, trainees, other specialities, the appropriate use of scarce resources, documentation, personal safety, mental health and burnout, research, clinical training/education, and audit. Imray stresses that “local decision making is key”.

Ngày 23/03/2020 | 06:35.

Straub Medical (United States), the US direct-sales subsidiary of Straub Medical AG (Switzerland), has announced the launch and first intervention performed with the Rotarex S atherectomy device designed for treating occlusive peripheral vascular disease (OPVD). 

Ngày 20/03/2020 | 08:19.

European CE mark has been awarded to the TriGUARD 3 cerebral embolic protection (CEP) device from Keystone Heart, a Venus Medtech Company.

Ngày 18/03/2020 | 09:41.

Endologix recently announced that it has received approval from the US Food and Drug Administration (FDA) for the Alto abdominal stent graft system (Alto).

Ngày 17/03/2020 | 08:20.

The American Journal of Kidney Diseases (AJKD) has published the National Kidney Foundation’s KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update, a completely revamped set of 26 individual guidelines for clinicians that focuses on dialysis access choices tailored to individual patients’ goals and preferences, as well as clinical outcomes.

Ngày 16/03/2020 | 09:40.

Abbott made history in January when it became the first company in the world to receive market approval for a transcatheter mitral valve implantation (TMVI) device. Its Tendyne system now has a CE-mark indication for the management of patients with mitral regurgitation who cannot undergo mitral valve surgery or percutaneous edge-to-edge repair (MitraClip). TMVI devices have been in the pipeline for years but, until now, none have been commercially available. In this interview, Nicolas Dumonteil (Clinique Pasteur, Toulouse, France) talks to Cardiovascular News about what the approval of Tendyne means for the management of patients with mitral regurgitation.

Ngày 14/03/2020 | 09:36.

The early months of 2020 have seen the emergence of new technologies in the intraoperative navigation space. Here, Vascular News considers Philips’ Fiber Optic RealShape (FORS) technology and Centerline Biomedical’s IntraOperative Positioning System (IOPS)—data on which have been presented at various meetings in recent months.

Ngày 13/03/2020 | 09:37.

Reflow Medical has announced that they have received US Food and Drug Administration (FDA) clearance for an expanded indication for the Wingman crossing catheter after completing the Wing-IT clinical trial. The Wingman catheter crosses peripheral chronic total occlusions (CTOs) using an extendable bevelled tip that creates a channel to help penetrate, or cross, the occlusion with a guidewire, enabling further treatment of the lesion with therapeutic devices.

Ngày 12/03/2020 | 09:14.

CryoLife has announced that it has received CE mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease. 


  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389